Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
897
-202
-18% -$69.1K 0.06% 141
2026
Q1
$387K Hold
1,099
0.09% 122
2025
Q4
$360K Hold
1,099
0.09% 122
2025
Q3
$310K Sell
1,099
-48
-4% -$13.9K 0.08% 133
2025
Q2
$320K Hold
1,147
0.09% 128
2025
Q1
$357K Sell
1,147
-4
-0.3% -$1.18K 0.11% 112
2024
Q4
$300K Buy
1,151
+3
+0.3% +$890 0.1% 112
2024
Q3
$370K Hold
1,148
0.12% 98
2024
Q2
$359K Buy
1,148
+62
+6% +$18.2K 0.12% 97
2024
Q1
$309K Hold
1,086
0.11% 109
2023
Q4
$313K Buy
1,086
+38
+4% +$10.4K 0.13% 102
2023
Q3
$282K Sell
1,048
-170
-14% -$42.4K 0.13% 108
2023
Q2
$270K Buy
1,218
+128
+12% +$29.7K 0.12% 110
2023
Q1
$264K Hold
1,090
0.13% 109
2022
Q4
$286K Sell
1,090
-78
-7% -$20.9K 0.14% 108
2022
Q3
$263K Sell
1,168
-143
-11% -$34.7K 0.16% 102
2022
Q2
$319K Sell
1,311
-400
-23% -$98K 0.19% 83
2022
Q1
$414K Sell
1,711
-100
-6% -$23K 0.22% 74
2021
Q4
$407K Sell
1,811
-609
-25% -$129K 0.2% 74
2021
Q3
$515K Buy
2,420
+142
+6% +$32.7K 0.26% 65
2021
Q2
$555K Sell
2,278
-40
-2% -$9.84K 0.3% 61
2021
Q1
$577K Buy
2,318
+888
+62% +$212K 0.34% 58
2020
Q4
$329K Buy
1,430
+2
+0.1% +$461 0.21% 76
2020
Q3
$363K Buy
1,428
+150
+12% +$37.2K 0.27% 66
2020
Q2
$301K Hold
1,278
0.23% 71
2020
Q1
$259K Buy
1,278
+10
+0.8% +$2.18K 0.24% 68
2019
Q4
$306K Buy
+1,268
New +$280K 0.22% 73

Other funds holding AMGN

Detalus Advisors's AMGN Position: Q2 2026 in Review

Detalus Advisors reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $69.1K and leaving 897 shares worth $325K. The position accounts for 0.06% of the portfolio, ranked #141.

Detalus Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $577K in Q1 2021. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Detalus Advisors held 897 shares of Amgen worth $325K as of Q2 2026.
  • Detalus Advisors sold 202 Amgen shares in Q2 2026, an estimated $69.1K.
  • Amgen made up 0.06% of Detalus Advisors's portfolio in Q2 2026, its #141 holding.
  • Detalus Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Detalus Advisors's Amgen position peaked at $577K in Q1 2021.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.